Effect of Antiplatelet Agents Combined with Cilostazol on Cardio-cerebrovascular Events and Bleeding Risk in Acute Coronary Syndrome Patients

被引：0
|
作者：
Jin, Xue-Mei [1 ]
Kim, Ye-Jee [2 ]
Yang, Bo Ram [1 ,3 ]
Choi, Nam-Kyong [2 ]
Lee, Joongyub [2 ]
Kim, Mi-Sook [1 ]
Shin, Ju-Young [2 ]
Seong, Jong-Mi [2 ]
Chang, Yoosoo [4 ]
Park, Byung-Joo [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Prevent Med, Seoul, South Korea
[2] Korea Inst Drug Safety & Risk Management, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea
[4] Sungkyunkwan Univ Sch, Kangbuk Samsung Hosp, Occupat & Environm Med, Seoul, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
667
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [31] Oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention: Balancing efficacy and bleeding risk
    Spinler, Sarah A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S7 - S17
  • [32] Cardio-Cerebrovascular Protective Effects of Valsartan in High-Risk Hypertensive Patients With Coronary Artery Disease (from the Kyoto Heart Study)
    Shiraishi, Jun
    Sawada, Takahisa
    Koide, Masahiro
    Yamada, Hiroyuki
    Matsubara, Hiroaki
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (09): : 1308 - 1314
  • [33] Effect of Antiplatelet Therapy on Cardiac Outcomes in Patients With Acute Coronary Syndrome
    Tanriverdi, Zulkif
    Besli, Feyzullah
    Gungoren, Fatih
    Altiparmak, Ibrahim Halil
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (07): : 896 - 896
  • [34] Patterns of antiplatelet use in patients with myocardial infarction and subsequent acute coronary syndrome events
    Yasmina, Alfi
    de Boer, Anthonius
    Klungel, Olaf H.
    Souverein, Patrick C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 119 - 119
  • [35] Homocysteine Is a Marker of Increased Cardio-Cerebrovascular Disease Risk in Psoriatic Patients, but It Does Not Reflect the Effect of Biological Therapy in the Longitudinal Observation
    Baloghova, Janette
    Feketeova, Eva
    Kolarcik, Peter
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022
  • [36] Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study
    Steenhuis, Dennis
    de Vos, Stijn
    Bos, Jens H. J.
    Hak, Eelko
    PREVENTIVE MEDICINE REPORTS, 2023, 34
  • [37] Meeting the needs for antiplatelet therapy in at-risk acute coronary syndrome patients
    不详
    CARDIOVASCULAR JOURNAL OF AFRICA, 2009, 20 (05) : 329 - 332
  • [38] Effect of body mass index on ischaemic and bleeding events in patients presenting with acute coronary syndromes: from the start antiplatelet registry
    Calabro, Paolo
    Moscarella, Elisabetta
    Gragnano, Felice
    Cesaro, Arturo
    Pafundi, Pia Clara
    Cesarano, Margherita
    Patti, Giuseppe
    Di Maio, Dario
    Cente, Marzia
    Cavallari, Maria
    Antonucci, Emilia
    Cirillo, Plinio
    Pignatelli, Pasuale
    Palareti, Gualtiero
    Sasso, Ferdinando Carlo
    Pengo, Vittorio
    Gresele, Paolo
    Marcucci, Rossella
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J161 - J161
  • [39] Predictors of gastrointestinal bleeding in patients with acute coronary syndrome and the optimal duration of dual antiplatelet therapy
    Wang, Yanyu
    Wu, Yingle
    Wang, Jingqiao
    Zhang, Hengliang
    Du, Laijing
    Wang, Ke
    Duan, Hongqiang
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2024, 29 (01):
  • [40] Has major in-hospital bleeding increased by increasing the use of antithrombotic and antiplatelet agents in the management of patients presenting with an acute coronary syndrome?
    Motivala, Apurva A.
    Saab, Fadi
    Li, Jin
    Kline-Rogers, Eva
    Froehlich, Jim
    Gurm, Hitinder
    Moscucci, Mauro
    Eagle, Kim
    CIRCULATION, 2006, 114 (18) : 862 - 862
12345